Cargando…

Outcomes of patients with lymph node metastasis treated with radical prostatectomy and adjuvant androgen deprivation therapy in a Chinese population: results from a cohort study

BACKGROUND: The aim of this study is to assess the prognosis of prostate cancer (PCa) with lymph node metastases (LNM) detected in pelvic lymph node dissection (PLND) after radical prostatectomy (RP) and adjuvant androgen deprivation therapy (ADT) in a Chinese population. METHODS: From June 2005 to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Xiaojian, Han, Chengtao, Zhang, Hailiang, Dai, Bo, Zhu, Yao, Shen, Yijun, Zhu, Yiping, Shi, Guohai, Ye, Dingwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426650/ https://www.ncbi.nlm.nih.gov/pubmed/25943443 http://dx.doi.org/10.1186/s12957-015-0597-3

Ejemplares similares

AB032. Penile rehabilitation using Vacuum Erection Device for erectile dysfunction after radical prostatectomy
por: Ye, Dingwei, et al.
Publicado: (2015)

Retrograde radical cystectomy and consequent peritoneal cavity reconstruction benefits localized male bladder cancer: results from a cohort study
por: Qin, Xiaojian, et al.
Publicado: (2015)

Adjuvant Treatment Approaches after Radical Prostatectomy with Lymph Node Involvement
por: Tavukçu, Hasan Hüseyin, et al.
Publicado: (2022)

Adding radiotherapy to androgen deprivation therapy in men with node-positive prostate cancer after radical prostatectomy: A meta-analysis
por: Guo, Lijuan, et al.
Publicado: (2020)

Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis
por: Lee, Hak J, et al.
Publicado: (2016)

Identification and validation of an 18-gene signature highly-predictive of bladder cancer metastasis
por: Wang, Beihe, et al.
Publicado: (2018)

Eliminating microscopic lymph node metastasis by performing pelvic lymph node dissection during radical prostatectomy for prostate cancer
por: Furubayashi, Nobuki, et al.
Publicado: (2020)

Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy
por: Ahn, Hyun Kyu, et al.
Publicado: (2020)

Prevalence of Lymph Node Metastasis in Radical Prostatectomy; A Retrospective and Multicenter Study in Iran
por: Ayati, Mohsen, et al.
Publicado: (2014)

Lymph swelling after radical prostatectomy and pelvic lymph node dissection
por: Carlsson, Stefan, et al.
Publicado: (2022)

Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer
por: Sato, Yuzuri Tsurumaki, et al.
Publicado: (2014)

Prediction of Biochemical Recurrence Based on Molecular Detection of Lymph Node Metastasis After Radical Prostatectomy
por: Özdemir, Berna C., et al.
Publicado: (2022)

Robotic Salvage Lymph Node Dissection After Radical Prostatectomy
por: Torricelli, Fabio C. M., et al.
Publicado: (2015)

Oncologic Outcomes of Lymph Node Dissection at Salvage Radical Prostatectomy
por: Preisser, Felix, et al.
Publicado: (2023)

Androgen receptor splice variant 7 detected by immunohistochemical is an independent poor prognostic marker in men receiving adjuvant androgen-deprivation therapy after radical prostatectomy
por: Ouyang, Wei, et al.
Publicado: (2021)

The Role of Radical Prostatectomy and Lymph Node Dissection in Clinically Node Positive Patients
por: Motterle, Giovanni, et al.
Publicado: (2019)

Extended lymph node dissection in robot-assisted radical prostatectomy: lymph node yield and distribution of metastases
por: Kim, Kwang Hyun, et al.
Publicado: (2014)

Impact of lymphovascular invasion on lymph node metastasis for patients undergoing radical prostatectomy with negative resection margin
por: Kang, Yong Jin, et al.
Publicado: (2017)

Complete androgen blockade vs. medical castration alone as adjuvant androgen deprivation therapy for prostate cancer patients following radical prostatectomy: a retrospective cohort study
por: Jin, Di, et al.
Publicado: (2022)

Androgen deprivation therapy plus apalutamide as neoadjuvant therapy prior radical prostatectomy for patients with unresectable prostate cancer
por: Wei, Yongbao, et al.
Publicado: (2023)

Neoadjuvant androgen-deprivation therapy with radical prostatectomy for prostate cancer in association with age and serum testosterone
por: Akitake, Naoko, et al.
Publicado: (2018)

Extended lymph node dissection in robotic radical prostatectomy: Current status
por: Chopra, Sameer, et al.
Publicado: (2016)

Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended? Of Course Not!
por: Sooriakumaran, Prasanna, et al.
Publicado: (2022)

Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended, of Course
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Expression of ARID1B Is Associated With Poor Outcomes and Predicts the Benefit from Adjuvant Chemotherapy in Bladder Urothelial Carcinoma
por: Wang, Beihe, et al.
Publicado: (2017)

B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma
por: Qin, Xiaojian, et al.
Publicado: (2013)

Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status
por: Wu, Junlong, et al.
Publicado: (2017)

Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma
por: Fangning, Wan, et al.
Publicado: (2017)

(68)Ga-PSMA ligand PET/CT integrating indocyanine green-guided salvage lymph node dissection for lymph node metastasis after radical prostatectomy
por: Li, Teng-Cheng, et al.
Publicado: (2021)

Androgen-deprivation therapy versus radical prostatectomy as monotherapy among clinically localized prostate cancer patients
por: Liu, Jinan, et al.
Publicado: (2013)

Complete PSA Remission without Adjuvant Therapy after Secondary Lymph Node Surgery in Selected Patients with Biochemical Relapse after Radical Prostatectomy and Pelvic Lymph Node Dissection
por: Winter, Alexander, et al.
Publicado: (2012)

Developing a personalized template for lymph node dissection during radical prostatectomy
por: Pathak, Ram A., et al.
Publicado: (2018)

Log Odds Could Better Predict Survival in Muscle-Invasive Bladder Cancer Patients Compared with pN and Lymph Node Ratio
por: Jin, Shengming, et al.
Publicado: (2019)

Predictive Value of Positive Surgical Margins after Radical Prostatectomy for Lymph Node Metastasis in Locally Advanced Prostate Carcinoma
por: Otto, Wolfgang, et al.
Publicado: (2012)

Selecting lymph node–positive patients for adjuvant therapy after radical prostatectomy and extended pelvic lymphadenectomy: An outcome analysis of 100 node-positive patients managed without adjuvant therapy
por: Tamhankar, Ashwin Sunil, et al.
Publicado: (2022)

Long-term treatment outcomes of intermittent androgen deprivation therapy for relapsed prostate cancer after radical prostatectomy
por: Maru, Shintaro, et al.
Publicado: (2018)

Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19
por: Sean Ong, Xuan Rui, et al.
Publicado: (2020)

Adverse Effect of Lymph Node Dissection in Metastatic Renal Cell Cancer Patients Treated with Cytoreductive Nephrectomy: A Contemporary Analysis of Survival
por: Cao, Dalong, et al.
Publicado: (2019)

Clinical value of extended pelvic lymph node dissection in patients subjected to radical prostatectomy
por: Dobruch, Jakub, et al.
Publicado: (2014)

Laparoscopic radical prostatectomy and extended pelvic lymph node dissection: a combined technique
por: Jarzemski, Piotr, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u7tu0c1nh2b93ton9oa87ra58a